InterventionsReview
Lipoprotein(a) as a Cardiovascular Risk Factor: Clinical Significance and Therapeutic Perspectives
Biomedicines
- Antisense oligonucleotides
- Cetp inhibitors
- Lipid and ceramide metabolism
- Lipoprotein
- Abdominal aortic aneurysm
- Humans
The paper
John Paul II Catholic University of Lublin · Institute of Cardiology
Biomedicines · 2 Aug 2026
